Multiple Myeloma

Showing NaN - NaN of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Multiple Myeloma Trial in Roma, Rome (ChIP-seq, NGS, ATAC-seq)

Recruiting
  • Multiple Myeloma
  • ChIP-seq, NGS, ATAC-seq
  • Roma, Italy
  • +1 more
May 24, 2023

Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)

Recruiting
  • Multiple Myeloma
  • ATAC-seq and ChIP-seq
  • Roma, Italy
  • +1 more
May 4, 2023

Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Orange, California
  • +270 more
Apr 11, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Benowa, Queensland, Australia
  • +132 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +87 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
Jan 17, 2023

Real-life Current Standards of Care in Relapsed and/or

Completed
  • Multiple Myeloma
  • No intervention
  • Tucson, Arizona
  • +85 more
Dec 20, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +107 more
Dec 20, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +150 more
Dec 9, 2022

Carfilzomib Among Multiple Myeloma Patients in Europe

Completed
  • Multiple Myeloma
    • Braunau, Austria
    • +114 more
    Dec 8, 2022

    Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +139 more
    Sep 9, 2022

    Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

    Active, not recruiting
    • Multiple Myeloma
    • +5 more
    • Duarte, California
    • +38 more
    Aug 18, 2022

    Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

    Recruiting
    • Multiple Myeloma
    • Orlando, Florida
    • +240 more
    Aug 18, 2022

    Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Woolloongabba, Queensland, Australia
    • +117 more
    Aug 3, 2022

    Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Tucson, Arizona
    • +67 more
    Jul 26, 2022

    Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • +3 more
    • Yuma, Arizona
    • +34 more
    Jul 22, 2022

    Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • +3 more
    • Tucson, Arizona
    • +131 more
    Jul 1, 2022

    Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

    Completed
    • Lymphoma
    • Multiple Myeloma
    • Muscle Shoals, Alabama
    • +215 more
    May 5, 2022

    Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • Alessandria, Italy
    • +41 more
    Mar 24, 2022

    Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Deletion 17P Syndrome
    • Ancona, Italy
    • +14 more
    Mar 24, 2022

    Multiple Myeloma Trial in Italy, Netherlands (CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE)

    Active, not recruiting
    • Multiple Myeloma
    • CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE
    • Rionero In Vulture, PZ, Italy
    • +12 more
    Mar 24, 2022

    Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Pom/dex (Pomalidomide plus low dose Dexamethasone)
    • Tucson, Arizona
    • +163 more
    Feb 25, 2022